Atirix Medical Systems Inc., based in Minneapolis, will reveal the latest release of its flagship product, the patented QC-Track system, at AHRA’s 45th Annual Meeting and Exposition being held July 9–12 in Anaheim, Calif.
The QC-Track 5.4 release introduces new capabilities for ultrasound quality control (QC), including American College of Radiology transducer phantom QC, as well as a workflow to track the ultrasound transducer HLD needed for “semicritical devices” used for intracavitary exams.
QC-Track 5.4 also includes enhancements to support the new FDA EQUIP process for Mammography Quality Standards Act compliance. The latest QC-Track features seek to make the sign-off process even more convenient for lead interpreting physicians.
For those attendees interested in the latest Joint Commission requirements, Atirix will also be displaying QC-Track’s enhancements and improvements to phantom QC for CT and MRI. There are also new capabilities for advanced phantom research, including the ability to generate detailed, slice-by-slice phantom data into a data cube for analysis.
Atirix offers products to diagnostic imaging centers to improve productivity and ensure compliance with federal, state and local regulations. The QC-Track system is an enterprise quality control information system for paperless device quality control, ACR CEU/CME and exam tracking, apron tracking, and preventive maintenance/service tracking.
